Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
It's whether you have the infrastructure to deliver it at scale
According to FDA labeling and American Diabetes Association guidelines, GLP-1 receptor agonists are indicated for type 2 diabetes (as an adjunct to diet and exercise) and for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Many users report success at 250mcg for mild to moderate injuries
Working with a dietitian alongside your therapy is the "secret sauce" to long-term success
A 2023 systematic review with meta-analysis showed that GLP-1 agonists significantly reduced body weight (11.7lb mean difference), body mass index (2.4kg/m2) and waist circumference (1.7 inches) in non-diabetic obese or overweight patients
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
